Segment information

6 Months Ended

Jul. 02, 2017

Segment Reporting [Abstract]

Segment information

Note 14 — Segment information

The following tables present the Company’s segment results for the three and six months ended July 2, 2017 and June 26, 2016:

	Three Months Ended				Six Months Ended
	July 2, 2017		June 26, 2016		July 2, 2017		June 26, 2016
	(Dollars in thousands)				(Dollars in thousands)
Revenue
Vascular North America	$	93,522	$	88,111	$	187,371	$	169,699
Anesthesia North America	49,081		49,194		97,288		95,151
Surgical North America	44,716		43,136		90,660		82,077
EMEA	131,962		131,705		262,695		253,800
Asia	63,988		63,191		112,941		112,347
OEM	45,132		40,298		88,478		74,275
All other	100,212		57,918		177,061		111,097
Consolidated net revenues	$	528,613	$	473,553	$	1,016,494	$	898,446

	Three Months Ended						Six Months Ended
	July 2, 2017			June 26, 2016			July 2, 2017			June 26, 2016
	(Dollars in thousands)						(Dollars in thousands)
Operating profit
Vascular North America	$	25,258		$	21,994		$	50,074		$	41,650
Anesthesia North America	20,516			15,050			34,043			27,227
Surgical North America	17,287			12,348			33,667			25,604
EMEA	23,250			23,944			45,490			44,987
Asia	18,604			21,751			29,402			34,759
OEM	10,337			9,215			19,458			14,404
All other	11,267			7,436			4,966			13,179
Total segment operating profit (1)	126,519			111,738			217,100			201,810
Unallocated expenses (2)	(16,317		)	(13,297		)	(46,079		)	(35,872		)
Income from continuing operations before interest, loss on extinguishment of debt and taxes	$	110,202		$	98,441		$	171,021		$	165,938

(1) Segment operating profit includes segment net revenues from external customers reduced by the segment's standard cost of goods sold, adjusted for fixed manufacturing cost absorption variances, selling, general and administrative expenses, research and development expenses and an allocation of corporate expenses. Corporate expenses are allocated among the segments in proportion to the respective amounts of one of several items (such as net revenues, numbers of employees, and amount of time spent), depending on the category of expense involved.

(2) Unallocated expenses primarily include manufacturing variances, with the exception of fixed manufacturing cost absorption variances, restructuring charges and gain on sale of assets.